MRX DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Marex Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important December 8 Deadline in Securities Class Action - MRX

Экспонаты Blokees на выставке CCXP25 в Бразилии -- мировая премьера нового продукта Saint Seiya

Blokees auf der CCXP25 in Brasilien: Weltpremiere des neuen Produkts Saint Seiya

Victory Fighting League CEO on Climbing MMA Popularity, TKO Rally

S&P 500: Sell Strength (Technical Analysis)

Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025

Netflix co-CEO reportedly discussed Warner Bros. deal with Trump

Why One Fund Just Bet $64 Million on a Healthcare Stock Down 63% This Past Year

Gentherm Stock Down 60% Since 2022 — But One Hedge Fund Just Bought 431,072 Shares

Where Will Quantum Computing Stock Be in 1 Year?

SL Green chief expects thriving NYC office market to continue — even under Mamdani

Halper Sadeh LLC Encourages Eagle Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Better Artificial Intelligence Stock: Palantir Technologies vs. Nvidia

Evaluating EPD Stock's Actual Performance

Why One Hedge Fund Has a $28 Million Bet on This Electronics Manufacturing Stock

Replicor publishes data from its compassionate access program in HBV/HDV

Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights

1 Growth Stock Down 27% to Buy Right Now

Why Norwegian Cruise Lines Fell Overboard in November

Disc Medicine, Inc. (IRON) Discusses ASH Conference Data Updates and Portfolio Progress Including Anemia and Iron Restriction Programs Transcript

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Jayud Global Logistics Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - JYD

This Artificial Intelligence (AI) Infrastructure Stock Could Be the Nvidia of 2026

AVTR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Avantor, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AVTR

DXCM DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - DXCM

Macquarie Value Fund Q3 2025 Sales And Purchases

Macquarie Value Fund Q3 2025 Contributors And Detractors

This Hedge Fund's Materion Stake Tops $38 Million as Earnings Strength Pushes Shares Near Record Highs

Prologis announces redemption of 3.00% Notes due 2026

Fed Rate Decision, Oracle, Costco, Broadcom, and More Stocks to Watch

Looking for Top ETFs? Here's One to Consider Now.

Silver (XAG) Forecast: Price Prediction Points Higher if Fed Confirms 2026 Rate Cuts

Hedge Fund Buys 622,500 Knowles Shares as Stock Outperforms S&P 500 — Should You?

Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake?

Think Palantir Stock Is Expensive? This 1 Chart Might Change Your Mind.

1 Quantum Computing Stock to Buy Hand Over Fist in December

Arons: 2026 Looks "Pretty Good," Likes AMZN, LULU, META

Vertex Stock: Why One Fund Lifted Its $94.3 Million Position Even as Shares Sank

Incyte Gets FDA Breakthrough Therapy Fast Track For Rare Blood Cancer Drug

Costco's Trump Lawsuit and Q1 2026 Earnings: What Investors Need to Watch

Warren Buffett Is Sending a Clear Warning As 2026 Approaches: 3 Things Investors Should Do

Apple's executive shake-up continues.

Why One Fund Just Put $23.5 Million Into Champion Homes Despite an 18% Stock Slide

UiPath Shares Surge. Is It Too Late to Buy the Stock?

2 Things Every GE Vernova Investor Needs to Know

Forget Medtronic, Buy This Healthcare Stock Instead

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

Centuri Stock Up 18% This Year: What a New $17 Million Position Signals for Investors

10 Energy Stocks to Buy Right Now

3 Top Stocks to Buy for 2026

BTDR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bitdeer Technologies Group Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

FDG: One Of The Few Outperformers In 2025

3 No-Brainer Growth Stocks to Buy for 2026 With $100 Right Now

EPU: A Mining ETF With A Large-Cap Bank

Evaluating VRT Stock's Actual Performance

Why One Investor Just Doubled Down on Clearwater Analytics Stock with a $45 Million Position

Oracle: Why This Selloff Looks Like An Early Christmas Gift

Apple stock under pressure after major executive departures: what it means for AAPL's AI roadmap

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Lantheus Holdings, Inc. (LNTH)

WPP DEADLINE TOMORROW: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages WPP plc Investors with Losses in Excess of $100K to Secure Counsel Before Important December 8 Deadline in Securities Class Action - WPP

3 Incredible Growth Stocks to Buy Now

Down 27%, Should You Buy Adobe Stock Before Dec. 10?

Financial Institutions Is Still Worth Banking On

'Trump accounts,' explained: Who qualifies, how they work and when you can claim

Netflix Stock Up 13%. Why $82.7 Billion $WBD Buy Makes $NFLX A Sell

Better Buy for 2026: ExxonMobil or Chevron?

Fulcrum Therapeutics, Inc. (FULC) Discusses New Clinical Data From the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease Transcript

Value Fund Cuts nCino Stake After $152 Million Quarter: What Long-Term Investors Should Know

Coinbase starts onboarding users again in India, plans for fiat on-ramp next year

Dyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DELIVER Clinical Trial of Z-Rostudirsen (DYNE-251) in Duchenne Muscular Dystrophy; Tomorrow, December 8 at 8:00 a.m. ET

American Electric Power: Unmatched Reach Make It A Buy

The Merger Fund Q3 2025 Contributors And Detractors

Brookfield, GIC near binding offer for National Storage, Bloomberg News reports

As Growth Accelerates, Is It Time to Buy CrowdStrike Stock?

Cellnex Telecom Is Now A 'Strong Buy'

Exxon Mobil's 43 Year Dividend Streak Looks Secure Despite Falling Earnings

3 Yield-Producing ETFs with Real Staying Power

'PROJECT TALON': Northrop Grumman reveals new 'autonomous wingman'

1 Vanguard ETF I'm Buying in 2026 and Holding Forever

NDMO: I Generally Get Cautious After Sharp Pops Higher (Rating Downgrade)

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO

Why 10%+ Yields Can Wreck Your Retirement Income

Prediction: Nvidia Stock Is Going to Soar Past $300 in 2026

Kessler Topaz Meltzer & Check, LLP Reminds StubHub Holdings, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit

How to trade Apple stock options

Best Marijuana Stocks to Watch Right Now

Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock

Core Scientific's Meltdown Over, Accelerating AI Monetization From FY 2026

Why QuantumScape Stock Got Crushed in November

Better ETF: Is VCLT's Focus on Corporate Bonds the Superior Approach to TLT's U.S. Treasuries?

Paloma Dumps 200,000 Lattice Semiconductor LSCC Shares in $9.8 Million Exit

Why I'm Buying This ETF Like There's No Tomorrow, and Never Selling

Anthony Scaramucci on Solana's Unsung Crypto Story, MSTR "Levered" Play

American Airlines requests notices in Spirit bankruptcy proceedings

Incyte's First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA

Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025

Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition

Rio Tinto: Reorganization First, Re-Rating Next

Nayax Considering an Offering of Notes and Warrants in Israel

2 Stocks That Could Soar by 52% and 282%, According to Wall Street

FNDA Is A Good Alternative To Large-Cap ETFs Like VUG